Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
Unilever and FDA recall certain Shedd’s Country Crock chilled side-dish products

Unilever and FDA recall certain Shedd’s Country Crock chilled side-dish products

Food allergies among children is increasing: Study

Food allergies among children is increasing: Study

New data on diagnosis and treatment of allergic diseases to be presented at the ACAAI meeting

New data on diagnosis and treatment of allergic diseases to be presented at the ACAAI meeting

Dietary options and better detection improve food allergy management procedures

Dietary options and better detection improve food allergy management procedures

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

Dey Pharma launches EpiPen Auto-Injector

Dey Pharma launches EpiPen Auto-Injector

Tips to prevent allergy during Halloween

Tips to prevent allergy during Halloween

Children rally for improved education and funding for food allergies

Children rally for improved education and funding for food allergies

Report assessing school-based policies that address the health of students released by AAFA

Report assessing school-based policies that address the health of students released by AAFA

FDA approves Hiberix Haemophilus influenzae type b vaccine

FDA approves Hiberix Haemophilus influenzae type b vaccine

FDA approves Helixate FS for routine prophylaxis in children with hemophilia A

FDA approves Helixate FS for routine prophylaxis in children with hemophilia A

FDA approves Extavia for multiple sclerosis

FDA approves Extavia for multiple sclerosis

Cremophor-based paclitaxel ‘chemo’ drug triggers fatal allergic reactions

Cremophor-based paclitaxel ‘chemo’ drug triggers fatal allergic reactions

Researchers find an increased rate of unintentional injection of epinephrine from auto-injectors for anaphylaxis

Researchers find an increased rate of unintentional injection of epinephrine from auto-injectors for anaphylaxis

European Commission and US FDA approve intravenous formulation of temozolomide

European Commission and US FDA approve intravenous formulation of temozolomide

CSL Behring receives FDA approval of RiaSTAP

CSL Behring receives FDA approval of RiaSTAP

New mouse model for peanut allergy

New mouse model for peanut allergy

Reactions to HPV vaccine Gardasil rare

Reactions to HPV vaccine Gardasil rare

New European food allergy research

New European food allergy research

New advances in diagnosis and treatment of allergic diseases

New advances in diagnosis and treatment of allergic diseases